The 2023 American Diabetes Association (ADA) Clinical Update Conference: February 10-12, 2023, to be held in person at the Westin Tampa Waterside Hotel and virtually. This format ensures an exceptional in-person learning experience, while also, enabling worldwide participation online. Consistent with ADA's high-quality professional education program, we have assembled an esteemed interdisciplinary professional planning committee to shape the content.
The Clinical Update Conference offers a first in-depth discussion at what's new in the ADA's Standards of Care in Diabetes—2023. All sessions will include practical clinical guidance on the latest evidence and newest clinical practice recommendations. This conference is designed for all health care professionals who provide clinical care and education for people with diabetes. Physicians, advanced practice providers (physician associates and nurse practitioners), nurses, dietitians, pharmacists, certified diabetes care and education specialists, mental health professionals, and others will benefit from this continuing education conference. Leading-edge information will be provided in a case-based format in this interactive learning environment.
Along with the 2023 updates to the ADA National Standards of Care in Diabetes, the following offers a sneak peek at our “Hope for Tomorrow” conference topics:
- The Emotional Side of Diabetes Messages
- Automated Insulin Delivery: The Ups and Downs
- Obesity Epidemic
- Diabetes Health in Women: Cardiovascular Risk, Eye Risk, and more
- Sustaining Behavioral Health with Diabetes Technology
View the program to learn more about our 2023 speakers and presentations.(link is external)
For prompt assistance with general questions, please contact conventionoperations@diabetes.org(link sends e-mail).
Thank you to the 2023 Clinical Update Conference Directors who develop, plan, and assess the educational content of the course to meet the needs of the Association’s diverse membership and constituencies. They provide the leadership necessary to ensure the course exceeds the quality criteria set forth by the American Diabetes Association.
Amy Hess-Fischl, MS, RD, LDN, BC-ADM, CDCES
Program Manager and Diabetes Care and Education Specialist
University of Chicago
Chicago, IL
Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES
Vice Chair and Associate Professor of Pharmacotherapy
Washington State University
Spokane, WA
Gretchen A. Piatt, MPH, PhD
Associate Professor
University of Michigan
Ann Arbor, MI
Michelle D. Stancil, RN, BSN, CDCES
Manager, Diabetes Management
Prisma Health-Upstate
Greenville, SC
Guillermo E. Umpierrez, MD, CDCES
Professor of Medicine
Emory University School of Medicine
Atlanta, GA